Skip to main content

Table 8 Characteristics of the malarial VL co-infected patients versus the non-malarial VL patients enrolled in the MSF’s clinical trial at Um-el-Kher and Kassab Hospitals, Sudan (1998)

From: Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study

Variable Cases n(%) Controls n(%) Crude Odds Ratio 95% Confidence Interval
Age 89 427   
Median (years), (interquartile range) 7 (4-14) 10 (6-17)   
Treatment center 89 427   
Kassab Hospital 17 (19.1) 134 (31.4) 1  
Um-el-Kher Hospital 72 (80.9) 293 (68.6) 1.94 1.10-3.41*
Fatal outcome 89 427   
No 79 (88.8) 415 (97.2) 1  
Yes 10 (11.2) 12 (2.8) 4.38 1.83-10.48*
Hb level 89 427   
Median (g/dl), (interquartile range) 7.5 (6.0-9.0) 8.2 (7.0-9.4)   
≥5.3 g/dl 75 (84.3) 405 (94.8) 1  
<5.3 g/dl 14 (15.7) 22 (5.2) 3.44 1.68-7.02*
Nutritional status 68 299   
Mean Weigh for Height (%) 78.8 80.4   
Weight for Height Percent ≥70% 60 (88.2) 279 (93.3) 1  
Weight for Height Percent <70% 8 (11.8) 20 (6.7) 1.86 0.78-4.42
Spleen size below the costal margin 80 389   
Median (cm), (interquartile range) 6 (3-8) 7 (4-10)   
<6 cm 33 (41.2) 144 (37.0) 1  
≥6 cm 47 (58.8) 245 (63.0) 0.84 0.51-1.37
Duration on-going sickness 86 422   
Median (days), (interquartile range) 30 (15-60) 30 (20-60)   
<60 days 62 (72.1) 286 (67.8) 1  
≥60 days 24 (27.9) 136 (32.2) 0.81 0.49-1.36
  1. *P-value <0.05 based on Person Chi-square test.